SCHEMBL3658726

SCHEMBL3658726

Cc1cc([N+]2(C3CCNC3)CCCC2C)ccc1NC(=O)COc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
RECQL P46063 1/20 0.44
POLB P06746 4/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
GAA P10253 2/20 0.41
KMT2A Q03164 3/20 0.40
LMNA P02545 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.39
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3651075 0.95 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C19RECQLPOLB
SCHEMBL3658110 0.89 KDM4E (0.44) CYP1A2CYP3A4CYP2C19POLBNPC1
Trifluoroacetic Acid SCHEMBL3653064 0.86 KDM4E (0.42) CYP1A2CYP3A4CYP2C19POLBNPC1
SCHEMBL3655137 0.83 RAB9A (0.43) RECQLNPC1RAB9AKMT2AALDH1A1
SCHEMBL3658418 0.83 NPC1 (0.48) POLBNPC1GAAKMT2AALDH1A1
SCHEMBL3659607 0.82 LMNA (0.33) RECQLKMT2ALMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL3655787 0.82 MLYCD (0.46) CYP1A2CYP2C19POLBNPC1RAB9A
SCHEMBL3654285 0.80 MAPT (0.38) RAB9AKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL3656321 0.79 KCNH2 (0.44) POLBNPC1RAB9AKMT2ALMNA
SCHEMBL3656206 0.79 KCNH2 (0.44) POLBNPC1RAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212282-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP disclosed
WO-2009052065-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed